The US100 and Wall Street as a whole is retreating in the second phase of today's session after very weak results from ASML, LVMH floated on the market. What's more, the selling pressure in the last few minutes is fueled by comments from the Fed's Mary Daly, who communicated that there is still a lot of work to be done in the fight against inflation, and that the Fed's neutral rate itself will not return to historical values, and will most likely now settle around 3%.
In Europe, but also in other markets, downward pressure today was driven by weak results from two key European companies:
LVMH's third quarter figures:
- Revenues: EUR 19.08 billion (estimate: EUR 20.05 billion)
Organic revenue: -3% (estimate +0.93%)
Fashion and leather goods division sales: -5% (estimate +0.48%)
Sales of organic products and spirits: -7% (estimate -2.41%)
ASML third quarter data:
- Orders: €2.63 billion, -53% k/k, estimate: €5.39 billion
- Net revenues: €7.47 billion, +20% k/k, estimate: €7.17 billion
- Gross margin: 50.8% vs. 51.5% k/k, estimate: 50.7%
- Net profit: €2.08 billion, +32% k/k, estimate: €1.91 billion
- Cash and other: €4.99 billion, -0.7% k/k, Estimate: €4.86 billion
ASML shares were losing 15% at the end of the session, while ADRs on LVMH shares are currently losing 10%.
US100 is currently losing 1.3% and going below yesterday's lows. For the moment, however, technically the uptrend is maintained all the time. Source: xStation
Morning wrap: Wall Street gains amid hopes of renewed US–Iran talks🗽
USA Rare Earth Acquires Key Brazilian Rare Earth Metal Mines ⛏️
US OPEN: Return of geopolitical concerns hits markets 💥
New Player in Google’s Ecosystem? Marvell Triggers Market Reaction
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
